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CASE REPORT
Pulmonary artery thrombosis in a patient with severe acute
respiratory syndrome
K H L Ng, A K L Wu, V C C Cheng, B S F Tang, C Y Chan, C Y Yung, S H Luk, T W Lee, L Chow,
K Y Yuen
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Severe acute respiratory syndrome (SARS) is an emerging
infectious disease with both pulmonary and extra-pulmonary
manifestations. Although coagulation abnormalities are
common in these patients, clinically overt thromboembolic
events are rarely reported. This report describes the first case
of pulmonary artery thrombosis in a patient with laboratory
confirmed SARS.
A
43 year old woman, working as a health care assistant
in a medical ward designated for the care of severe
acute respiratory syndrome (SARS) patients during the
outbreak in 2003, was admitted because of fever, dry cough,
diarrhoea, chills, and rigor for two days. On admission, she
had a temperature of 38.5 C˚. Physical examination showed
bilateral basal crepitations. Preliminary investigations
showed a normal white cell count (5700 cells/ml, normal
range 4000–11000 cells/ml), but her lymphocyte count was
depressed (1000 cells/ml, normal range 1500–4000 cells/ml).
The platelet count was normal on admission (2946109/l,
normal range 150–4006109/l), and the coagulation profile
was unremarkable at that time. Liver and renal function tests
were also normal. The chest radiograph showed bilateral
lower zone consolidations (fig 1). High resolution computed
tomography of the thorax showed ground glass opacities at
lingular segment, left upper, and right lower lobes (fig 2). In
view of the possible occupational exposure, a clinical
diagnosis of SARS was made. She was given intravenous
ribavirin 400 mg every eight hours and oral prednisolone
25 mg twice daily. One week after admission, the patient
complained of increasing severity of dyspnoea and oxygen
desaturation. Repeated chest radiography showed deteriora-
tion with worsening of right mid-zone shadow. Lopinavir
(400 mg)/ritonavir (100 mg) (Kaletra) twice daily was
added, and intravenous pulse methylprednisolone 500 mg
daily was started for three consecutive days (from day 7 to
10), followed by tailing dose of corticosteroids. Despite
resolution of fever, her symptoms continued to deteriorate
and required intensive care on day 13. Chest radiography
showed florid ground glass appearances in both lung fields.
Intravenous immunoglobulin (IVIg) 21 gm daily and subse-
quently intravenous pentaglobulin 300 mg daily were given
between day 13 and day 16. Her clinical course remained
stable thereafter although the chest radiograph findings were
static in the next 10 days. On day 27, she had recurrence of
low grade fever and dyspnoea. ECG showed sinus tachycardia
at about 120 beats per minute. Blood picture showed
progressive thrombocytopenia (to a nadir of 356109/l),
associated with prolonged prothrombin (17.6 seconds, nor-
mal range 10.4 to 12.6 seconds) and activated partial
thromboplastin time (39.2 seconds, normal range 24.5 to
37.6 seconds). The level of D-dimer was also raised (.1,
normal range ,0.5 mg/ml), suggesting the presence of
disseminated intravascular coagulation. Septic investigation
for nosocomial infection was negative. Doppler ultrasound of
lower limbs did not show any deep vein thrombosis.
However, the CT angiogram of the thorax detected the
presence of a blood clot in the right main pulmonary artery
with extension into the segmental artery of the right lower
lobe, suggestive of thromboembolism (figs 3 and 4).
Anticoagulation therapy in terms of nadroparin calcium
Abbreviations: SARS, severe acute respiratory syndrome; IVIg,
intravenous immuonoglobulin; PAT, pulmonary artery thrombosisFigure 1 Chest radiograph.
Figure 2 High resolution computed tomography of the thorax.
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(Fraxiparine, Sanofi-Winthrop, Gentilly, France) was started.
Her symptoms gradually improved and subsided. After
prolonged period of convalescence, the patient was finally
discharged from hospital. Subsequent examination for
underlying thrombophilia, including protein C and S assays,
and lupus anticoagulant all turned out to be negative. The
patient was not taking any contraceptive pills or other drugs
before admission. The microbiological diagnosis of SARS was
retrospectively confirmed by a fourfold rise of antibody titre
against SARS associated coronavirus (SARS-CoV) by indirect
immunofluorescence test (from a titre of ,25 taken on day
10 to a value of 800 on day 27), and positive reverse
transcription polymerase chain reaction (RT-PCR) results in
sputum and saliva on day 14 after onset of symptoms.
DISCUSSION
SARS, a newly described infectious disease caused by a novel
coronavirus,1 has been responsible for infecting more than
8000 people and killing in excess of 700 worldwide since its
emergence last year.2 The clinical manifestations and
laboratory abnormalities of SARS have been well summarised
elsewhere.3 4 Various coagulation abnormalities such as
prolonged activated partial thromboplastin time and raised
D-dimers have been reported previously in up to 65% and 45%
of adult SARS patients respectively,5 6 and multiple necropsy
series of SARS patients showed that vascular thromboses
were not uncommonly seen in lung specimens,7 8 suggesting
the possibility of an underlying thrombophilic state with
predisposition to thrombus formation in the lungs. Of note,
in a recently published necropsy series comprising a total of
eight SARS patients,9 it was found that four patients had
pulmonary thromboemboluses within the pulmonary
arteries, three had deep venous thrombosis, and one patient
had marantic valvular vegetations associated with infarctions
of the heart, kidneys, spleen, and occipital lobe. In addition,
based on the experience at a SARS hospital intensive care
unit in Singapore,9 it was found that 20.5% of patients had
deep vein thrombosis, and 11.4% showed clinical evidence of
pulmonary embolism. In our case, the radiological appear-
ance of the lesion, together with absence of thromboembo-
luses in the contralateral side of the lung and the lack of
evidence of deep vein thrombosis, favour the diagnosis of
pulmonary artery thrombosis (PAT).10 11 PAT has been
reported to be associated with drug induced, systemic, or
intrinsic causes of thrombophilia, as well as with pulmonary
artery occlusion by tumours.12 13 Although PAT can run a
chronic course resulting in cor pulmonale, acute massive PAT
can also occur. Such a presentation can occur in our patient,
given that PAT has been reported in the setting of severe
pulmonary parenchymal disorders such as tuberculous or
mycotic pneumonia.12 13 Moreover, the use of IVIg in our
patient might have contributed to the development of a
hypercoagulable state, as there have been reports of strokes
occurring during or shortly after infusions of the drug in
patients with antoimmune haematological and neuromus-
cular disorders;14–16 interestingly, there has been a recent
report of five SARS patients developing large artery ischaemic
strokes, three of which had received IVIg for treatment of
SARS.17 These factors, together with the presence of
disseminated intravascular coagulation in our patient,18 19
might have contributed to the development of pulmonary
thromboembolism. We believe the suggestion that a subset of
SARS patients with raised D-dimer levels might benefit from
anticoagulation therapy should be re-examined in the light of
our experience.20 Pulmonary embolism may present with
clinical deterioration such as unexplained haemodynamic
instability or hypoxemia, or both, as occurred in our patient.
In our opinion, as well as the experience reported else-
where,9 17 we believe that this phenomenon may be more
common than is generally appreciated. Clinicians should be
more alert to this uncommonly reported complication and
have low thresholds for starting appropriate investigations
and treatments in this particular group of patients.
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Figure 3 Computed tomography pulmonary angiogram.
Figure 4 Computed tomography pulmonary angiogram.
Learning points
N Patients with SARS may be prone to pulmonary
thromboembolic events attrributable to an underlying
thrombophilic state.
N Pulmonary embolism may present with clinical dete-
rioration such as unexplained haemodymaic instability
or hypoxemia, or both, in a patient with SARS.
N Clinicians caring for SARS patients must maintain a
high index of suspicion for the occurrence of pulmon-
ary thromboembolism in their patients.
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